We report a case of bifacial weakness with paresthesia, a recognized Guillain-Barré
syndrome subtype characterized by rapidly progressive facial weakness and paresthesia …

We present a case of facial diplegia after 10 days of SARS-CoV-2 confirmed infection
symptoms in a 61 year old patient without prior clinically relevant background. There are few …

During the recent coronavirus disease 2019 (COVID-19) outbreak in Northern Italy, we
observed a 57-year-old man developing acute motor-sensory axonal neuropathy, a variant …

There is growing evidence of neurological involvement in patients with coronavirus disease
19 (COVID-19), suggesting that Guillain-Barre syndrome (GBS) can also occur with severe …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in
December 2019 and is the cause of the ongoing worldwide pandemic of coronavirus …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
infectious agent responsible for coronavirus disease 2019 (COVID-19). Respiratory and …

The novel coronavirus disease 2019 (COVID-19) is a global pandemic. Although the main
clinical manifestations of the COVID-19 infection have confined to the respiratory system …

The global SARS-CoV-2 pandemic posed an unprecedented challenge to almost all fields of
medicine and Neurology is not an exception. Collecting information about its complications …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak emerged in
December 2019 in South-Eastern China and rapidly spreaded throughout the globe …

We read with interest the report of Guillain-Barré syndrome secondary to SARS-Cov-19
infection (Coen et al. 2020). Recently, there have been multiple reports of Guillain-Barré …